{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:31:15Z","timestamp":1762475475447,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jdcr.2023.04.013","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T21:19:13Z","timestamp":1682371153000},"page":"73-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Topical ruxolitinib for the treatment of granuloma faciale"],"prefix":"10.1016","volume":"36","author":[{"given":"Alan","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Stahly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Kieffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0783-6180","authenticated-orcid":false,"given":"Charles","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Nathoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2023.04.013_bib1","series-title":"StatPearls","article-title":"Granuloma faciale","author":"Al Dhafiri","year":"2022"},{"issue":"11","key":"10.1016\/j.jdcr.2023.04.013_bib2","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jamadermatol.2018.2681","article-title":"Assessment of treatment of refractory granuloma faciale with intralesional Rituximab","volume":"154","author":"Morgado-Carrasco","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jdcr.2023.04.013_bib3","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.4081\/dr.2010.e17","article-title":"The interaction of inflammatory cells in granuloma faciale","volume":"2","author":"Nakahara","year":"2010","journal-title":"Dermatol Rep"},{"issue":"5","key":"10.1016\/j.jdcr.2023.04.013_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1600-0560.1993.tb00668.x","article-title":"Immunophenotypic analysis suggests that granuloma faciale is a gamma-interferon-mediated process","volume":"20","author":"Smoller","year":"1993","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jdcr.2023.04.013_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jdcr.2023.01.016","article-title":"Refractory granuloma faciale successfully treated with adjunct topical JAK inhibitor","volume":"33","author":"Chen","year":"2023","journal-title":"JAAD Case Rep"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623001297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623001297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:25:54Z","timestamp":1762475154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512623001297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":5,"alternative-id":["S2352512623001297"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.04.013","relation":{},"ISSN":["2352-5126"],"issn-type":[{"type":"print","value":"2352-5126"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical ruxolitinib for the treatment of granuloma faciale","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}